The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis that need to be treated with IV antibiotics. Do participants have the same improvement in lung function with one type of antibiotic (called beta-lactams) versus taking two different types of antibiotics (tobramycin and beta-lactams)?
Patient 6 years and older.
Patients with a history of lung transplant.
Therapeutic Development Network (TDN)
Research Institute
(330) 543-3193
research@akronchildrens.org
Medical Director, Pulmonary Function Testing Lab & Ventilator and Respiratory Technology Program; Pediatric Pulmonologist
Lewis H. Walker, MD, Cystic Fibrosis CenterPediatric Neuromuscular ClinicRobert T. Stone, MD, Respiratory Center
While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...
By using this site, you consent to our use of cookies. To learn more, read our privacy policy.
